News - 2005
November 15, 2005: Read about GPEx®, Gala's proprietary cell line development technology recently published in the September/October edition of Bioprocessing Journal
July 8, 2005: Cardinal Health Completes Its First Manufacturing Project of an Antibody Using a Cell Line Made with Its Gene Expression Technology
June 2005: Cardinal Health Enters Agreement For Mammalian Cell Line Engineered With Its GPEx® Patented Technology. "Cell Line to Express Experimental Cancer Antibody"
May 2005: Gala Biotech, a Business Unit of Cardinal Health, Enters Cell Line Engineering Collaboration with Cambridge Antibody Technology
April 2005: Cardinal Health Receives Patent for Mammalian Cell Genetic Engineering Technology
Home About Us Gala Capabilities Working with Gala Employment News Contact Us